The effects of various fatty acids on the ligand-binding sites of human serum albumin (HSA) were investigated. The present results provide evidence for the independence of the four classified binding sites and for the existence of distinct high-affinity sites for long-chain (C12-C18) and for medium-chain (C6-C10) fatty acids. The binding of long-chain fatty acids to HSA at low molar ratios (0.5-2.0) of fatty acid to HSA caused marked conformational changes. Site I and the bilirubin-site were sensitive to these conformational changes : Site I became asymmetrical and the bilirubin-site acquired a cooperative nature. On the other hand, the diazepam-site and Site II were little affected. The binding of medium-chain fatty acids to HSA at low molar ratios (vide supra) caused competitive ligand displacement. These acids did not change the comformation of HSA, but they perturbed Site II to a limited extent, making Site II more aymmetric. These effects enhanced the circular dichroism spectrum of flufenamic acid-HSA complex. These results confirmed that the diazepam-site and Site II are distinct sites.At a high molar excess (4.0-8.0) of fatty acid to HSA, the binding of ligands to HSA was inhibited in a complicated manner that appeared to reflect a combination of competitive effects and conformational changes.
No takes yet. Share an insight, caveat, or question.
Maruyama et al. (1986) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: